Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Wright

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
American Heart Journal Plus : Cardiology Research and Practice|December 25, 2025
Cardiac troponin T elevation predicts mortality in hospitalized COVID-19 patientsKatelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Cardiac Troponin T Elevation Predicts Mortality in Hospitalized COVID-19 PatientsKatelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Transfusion|May 26, 2021
Use of convalescent plasma in COVID-19 patients with immunosuppressionJonathon W Senefeld, Stephen A Klassen, Shane K Ford, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysisStephen A Klassen, Jonathon Senefeld, Patrick W Johnson, et al.
Mayo Clinic Proceedings|May 7, 2021
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysisStephen A Klassen, Jonathon W Senefeld, Patrick W Johnson, et al.
The New England Journal of Medicine|March 18, 2017
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk PatientsPaul M Ridker, James Revkin, Pierre Amarenco, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 PatientsMichael Joyner, R Scott Wright, DeLisa Fairweather, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
American Heart Journal Plus : Cardiology Research and Practice|December 25, 2025
Cardiac troponin T elevation predicts mortality in hospitalized COVID-19 patientsKatelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Cardiac Troponin T Elevation Predicts Mortality in Hospitalized COVID-19 PatientsKatelyn A Bruno, R Scott Wright, Joshua Culberson, et al.
Transfusion|May 26, 2021
Use of convalescent plasma in COVID-19 patients with immunosuppressionJonathon W Senefeld, Stephen A Klassen, Shane K Ford, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysisStephen A Klassen, Jonathon Senefeld, Patrick W Johnson, et al.
Mayo Clinic Proceedings|May 7, 2021
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysisStephen A Klassen, Jonathon W Senefeld, Patrick W Johnson, et al.
The New England Journal of Medicine|March 18, 2017
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk PatientsPaul M Ridker, James Revkin, Pierre Amarenco, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 PatientsMichael Joyner, R Scott Wright, DeLisa Fairweather, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 20